Forskolin and rutin prevent intraocular pressure spikes after Nd:YAG laser iridotomy

Panminerva Medica

Volumn 54, Issue 4 SUPPL. 1, 2012, Pages 77-82

  Nebbioso, M ^a   Belcaro, G ^b   Librando, A ^a   Rusciano, D ^c   Steigerwalt, R D ^a   Pescosolido, N ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Sooft Italia SpA   (Italy)

Author keywords

Forskolin; Glaucoma; Intraocular pressure; Iridotomy; Nd:YAG laser; Rutin; Vitamin B

Indexed keywords

EID: 84876590563     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Del Priore LV, Robin AL, Pollack IP. Neodymium: YAG and argon laser iridotomy. Long-term follow-up in a prospective, randomized clinical trial. Ophthalmology 1988;95:1207-11.
2. Schrems W, Eichelbrönner O, Krieglstein GK. The immediate IOP response of Nd-YAG-laser iridotomy and its prophylactic treatability. Acta Ophthalmol (Copenh) 1984;62:673-80.
3. Shani L, David R, Tessler Z, Rosen S, Schneck M, Yassur Y. Intraocular pressure after neodymium:YAG laser treatments in the anterior segment. J Cataract Refract Surg 1994;20:455-8.
4. Krupin T, Stone RA, Cohen BH, Kolker AE, Kass MA. Acute intraocular pressure response to argon laser iridotomy. Ophthalmology 1985;92:922-6.
5. Blackwell C, Hirst LW, Kinnas SJ. Neodymium-YAG capsulotomy and potential blindness. Am J Ophthalmol 1984;98:521-2.
6. Hsieh JW. Effects of timolol and acetazolamide on intraocular pressure elevation following argon laser iridotomy. J Formos Med Assoc 1992;91:29-33.
7. Chen TC. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery. J Cataract Refract Surg 2005;31:1707-12.
8. Pescosolido N, Librando A, Puzzono M, Nebbioso M. Palmi-toylethanolamide effects on intraocular pressure after Nd: YAG laser iridotomy: an experimental clinical study. J Ocul Pharmacol Ther 2011;27:629-35.
9. Vishwakarma RA, Tyagi BR, Ahmed B, Husain A. Variation in forskolin content in the roots of coleus forskohlü. Planta Med 1988;54:471-2
10. Seamon KB, Daly J W. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res 1981;7:201-24
11. Caprioli J, Sears M. Forskolin lowers intraocular pressure in rabbits, monkeys, and man. Lancet 1983;1:958-60.
12. Pescosolido N, Librando A. Oral administration of an association of forskolin, rutin and vitamins Bl and B2 potentiates the hypotonis-ing effects of pharmacological treatments in POAG patients. Clin Ter 2010;161:e81-5.
13. Park YH, Chiou GC. Structure-activity relationship (SAR) between some natural flavonoids and ocular blood flow in the rabbit. J Ocul Pharmacol Ther 2004;20:35-42.
14. Xu XR, Park YH, Chiou GC. Effects of dihydrogenation of flavones and number of hydroxy groups in the molecules on ocular blood flow in rabbits and retinal function recovery in rats. J Ocul Pharmacol Ther 2004;20:311-20.
15. Park YH, Xu XR, Chiou GC. Structural requirements of flavonoids for increment of ocular blood flow in the rabbit and retinal function recovery in rat eyes. J Ocul Pharmacol Ther 2004;20:189-200.
16. Chiou GC, Xu XR. Effects of some natural flavonoids on retinal function recovery after ischemic insult in the rat. J Ocul Pharmacol Ther 2004;20:107-13.
17. Nebbioso M, De Gregorio F, Prencipe L, Pecorella I. Psychophysical and electrophysiological testing in Ocular Hypertension. Optom Vision Sci 2011;88:1-12.
18. Er H, Doganay S, Evereklioglu C, Turkoz Y, Gündüz A, Borazan M, Ozyalin F. Comparison of the effects of argon and neodymium:YAG laser iridotomy on cytokines in the rabbit aqueous humor. Eur J Ophthalmol 2002;12:183-7.
19. Kawai K, Sugiyama K, Kitazawa Y. The effect of alpha2-agonist on IOP rise following Nd-YAG laser iridotomy. Tokai J Exp Clin Med. 2004; 29:23-6.
20. Caprioli J, Sears M, Bausher L, Gregory D, Mead A. Forskolin lowers intraocular pressure by reducing aqueous inflow. Invest Ophthalmol Vis Sci 1984;25:268-77.
21. Caprioli J, Sears M. The adenylate cyclase receptor complex and aqueous humor formation. Yale J Biol Med 1984;57:283-300.
22. Shen X, Koga T, Park BC, SundarRaj N, Yue BY. Rho GTPase and cAMP/protein kinase A signaling mediates myocilin-induced alterations in cultured human trabecular meshwork cells. J Biol Chem 2008;283:603-12.
23. Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hobo-ken) 2010;67:545-54.
24. Zhang M, Maddala R, Rao PV. Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork. Am J Physiol Cell Physiol 2008;295:C 1057-70.
25. Ramachandran C, Satpathy M, Mehta D, Srinivas SP. Forskolin induces myosin light chain dephosphorylation in bovine trabecular meshwork cells. Curr Eye Res 2008;33:169-76.
26. Kaufman PL. Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail. Exp Eye Res 2008;86:3-17.
27. Honjo M, Inatani M, Kido N, Sawamura T, Yue BY, Honda Y, Tani-hara H. Effects of protein kinase inhibitor, HA 1077, on intraocular pressure and outflow facility in rabbit eyes. Arch Ophthalmol 2001;119:1171-8
28. Honjo M. The possibility of selective Rho-associated kinase (ROCK) inhibitors as a medical treatment for glaucoma. Nihon Ganka Gakkai Zasshi 2009; 113:1071-81.
29. Mira L, Fernandez MT, Santos M, Rocha R, Florencio MH, Jennings KR. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 2002;36:1199-208.
30. Park YH, Chiou GC. Structure-activity relationship (SAR) between some natural flavonoids and ocular blood flow in the rabbit. J Ocul Pharmacol Ther 2004;20:35-42.
31. Bauer AT, Burgers HK, Rabie T, Marti HH. Matrix metallopro-teinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 2010;30:837-48.
32. Pescosolido N, Cavallotti C, Rusciano D, Nebbioso M. Trabecular meshwork in normal and pathological eyes. Ultrastruct. Pathol 2012;36:102-107.
33. Meyer-Franke A, Kaplan MR, Pfrieger FW, Barres BA. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 1995;15:805-19.
34. Kilmer SL, Carlsen RC. Forskolin activation of adenylate cyclase in vivo stimulates nerve regeneration. Nature 1984;307:455-7.
35. Ji Y, Pang PT, Feng L, Lu B. Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hip-pocampal neurons. Nat Neurosci 2005;8:164-72.
36. Juric DM, Loncar D, Carman-Krzan M. Noradrenergic stimulation of BDNF synthesis in astrocytes: mediation via alpha 1- and betal/ beta2-adrenergic receptors. Neurochem Int 2008;52:297-306
37. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, Sun B. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000;470:113-7
38. Meyer-Franke A, Wilkinson GA, Kruttgen A, Hu M, Munro E, Hanson MG Jr, et al. Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron 1998;21:681-93.
39. Hu Y, Cui Q, Harvey AR. Interactive effects of C3, cyclic AMP and ciliary neurotrophic factor on adult retinal ganglion cell survival and axonal regeneration. Mol Cell Neurosci 2007;34:88-98.
40. Cui Q, Yip HK, Zhao RC, So KF, Harvey AR. Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neurosci 2003;22:49-61.
41. Nakayama M, Aihara M, Chen YN, Araie M, Tomita-Yokotani K, Iwashina T. Neuroprotective effects of flavonoids on hypoxia-, glutamate-, and oxidative stress-induced retinal ganglion cell death. Mol Vis 2011;17:1784-1793.